KURA (KURA) Stock Price & Analysis
KURA (KURA) rose 0.00% to USD 10.39 as of July 25, 2026 at 04:37 UTC, according to Nexqual real-time market data.
KURA last closed at USD 10.39; the session ranged USD 10.21–10.51 on volume of 1,137,952 shares. Market capitalization is —, with a 52-week range of USD 5.45–12.49 (NMS). Source: Nexqual, July 25, 2026 at 04:37 UTC.
Key Statistics (as of July 25, 2026 at 04:37 UTC)
| Price | USD 10.39 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.39 |
| Open | USD 10.39 |
| Day Range | USD 10.21 – 10.51 |
| 52-Week Range | USD 5.45 – 12.49 |
| Volume | 1,137,952 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KURA)
Nexqual's technical model rates KURA "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 04:37 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 48.75 (neutral) |
| vs SMA50 | Above (USD 10.2) |
| MACD | 0.11 (positive) |
Analyst Ratings (KURA)
Wall Street analysts rate KURA "Strong Buy" based on 12 analysts, with a mean price target of USD 31.17 (range USD 15–76), per Nexqual as of July 25, 2026 at 04:37 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 12 |
| Mean Target | USD 31.17 |
| High Target | USD 76 |
| Low Target | USD 15 |
| Buy / Hold / Sell | 14 / 1 / 0 |
From KURA's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.81 | ▼ 5.62% |
| ANAB | AnaptysBio, Inc. | USD 54.15 | ▲ 2.93% |
| RGNX | REGENXBIO Inc. | USD 9.73 | ▼ 4.61% |
| XNCR | Xencor, Inc. | USD 19.44 | ▼ 0.36% |
| PTGX | Protagonist Therapeutics, Inc. | USD 136.11 | ▲ 0.49% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:37 UTC. This page is informational and not investment advice.